University of North Carolina, Chapel Hill: Autism Spectrum Disorder trials

The registry lists 16 Autism Spectrum Disorder studies with University of North Carolina, Chapel Hill as lead sponsor. 3 are open to participants now and 7 have results posted.

Phase 1 2Phase 2 2Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Resources for Optimizing Outcomes in Toddlers on the SpectrumRecruitingNCT07086781Not applicable
• Physical Activity and Community EmPOWERment ProjectRecruitingNCT06740162Not applicable
• A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism SpectrumEnrolling by invitationNCT05398250Not applicable
• Expediting Access to Services for EquityTerminatedNCT06291246Not applicableResults posted
• North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2CompletedNCT03548779Not applicableResults posted
• Evaluation of a Novel Intervention for Infants At Risk for Neurodevelopmental DisordersCompletedNCT03388294Not applicableResults posted
• Sulforaphane for the Treatment of Young Men With Autism Spectrum DisorderCompletedNCT02909959Phase 2Results posted
• Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyCompletedNCT01269710Results posted
• FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum DisordersCompletedNCT01028820Phase 4Results posted
• Study of Aripiprazole to Treat Children and Adolescents With AutismCompletedNCT00619190Phase 2Results posted
• Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic AdultsActive, not recruitingNCT06060860Not applicable
• Examining the Efficacy of the T-STEPCompletedNCT04612231Not applicable
• Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine TreatmentWithdrawnNCT02353130
• Brain Imaging of Intranasal Oxytocin Treatment in AutismCompletedNCT01945957Phase 1
• Brain Connectivity in Neurodevelopmental Disorders in Response to TreatmentCompletedNCT01364818
• Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum DisordersCompletedNCT00609531Phase 1